SCHEMBL4337058

SCHEMBL4337058

CC(C)OC(Cc1cn(C)c2ccc(OCC(O)COc3cc(Cl)ccc3Cl)cc12)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4A P47712 1/20 0.41
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
CPT1A P50416 2/20 0.36
CPT1B Q92523 2/20 0.36
CPT2 P23786 1/20 0.36
LMNA P02545 1/20 0.36
HSP90AA1 P07900 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ADA P00813 1/20 0.35
MTNR1A P48039 4/20 0.34
MTNR1B P49286 4/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MCL1 Q07820 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4343659 0.93 PLA2G4A (0.41) PLA2G4AMEN1KMT2ACPT1ACPT1B
SCHEMBL4329911 0.91 PLA2G4A (0.44) PLA2G4ALMNAHSP90AA1HTTSMN1; SMN2
SCHEMBL4341174 0.90 PPARG (0.38) PLA2G4AMEN1KMT2ALMNASMN1; SMN2
SCHEMBL4342749 0.89 PLA2G4A (0.42) PLA2G4AKMT2ALMNAHSP90AA1HTT
SCHEMBL4335047 0.88 PLA2G4A (0.38) PLA2G4AADAMTNR1AMTNR1BMCL1
SCHEMBL4328073 0.88 PLA2G4A (0.38) PLA2G4ACPT1ACPT1BCPT2LMNA
SCHEMBL13819541 0.86 PLA2G4A (0.36) PLA2G4AKMT2ALMNAHSP90AA1HTT
SCHEMBL4339112 0.84 MRGPRX4 (0.36) PLA2G4AMTNR1AMTNR1BCYP2C9MCL1
SCHEMBL4333190 0.84 TP53 (0.37) MEN1KMT2ASMN1; SMN2MTNR1AMTNR1B
SCHEMBL4331747 0.82 PPARG (0.42) PLA2G4AMEN1KMT2ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 PLA2G4A 3556/4885MEN1 4091/4885KMT2A 2774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.